OUR COMPANY
OUR TECHNOLOGY
SOLUTIONS
PARTNERSHIPS
RESEARCH & EVIDENCE
IN THE NEWS
HOW IT WORKS
INVEST
CONTACT US
INVEST
Media Coverage
< Back to all News items
31/10/2021
OncoHost’s Algorithms Predict Cancer Patients Response To Treatments
Read More>
20/09/2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients’ Immunotherapy Response
Read More>
20/09/2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients’ Immunotherapy Response
Read More>
20/09/2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients’ Immunotherapy Response
Read More>
10/09/2021
Oncohost platform predicts response to lung cancer therapy
Read More>
25/08/2021
Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test
Read More>
20/08/2021
OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices
Read More>
19/08/2021
OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices
Read More>
19/08/2021
Global Roundup: Sweden’s Cellink Rebrands as BICO and Other News
Read More>
06/07/2021
Oncohost’s Focus on the Patient Offers Precision Oncology To Combat Cancer
Read More>
«
1
2
3
4
…
8
»